Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
Launched by CRYOLIFE, INC. · Nov 15, 2017
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
Prospective, concurrent 4D flow Magnetic Resonance Imaging (MRI) and echocardiography of On-X and St Jude Medical (SJM) Masters HP or Carbomedics Carbo-seal or Carbo-seal Valsalva aortic valve replacement (AVR) patients will be performed. Echocardiography analysis will include: valve function (opening angle), pressure gradients, and degree of valve washout. MRI analysis will focus on downstream flow patterns (helicity and vorticity), energy loss, pressure recovery, and measurement of wall shear stress in the anastomosis regions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female subjects 18-89 years of age
- • Patients with aortic valve disease who within the last five years underwent AVR using the On-X aortic valve, SJM Masters HP, or Carbomedics aortic valves.
- Exclusion Criteria:
- • Patients contraindicated against MRI
- • Patients with pacemakers, cochlear (in the ear) implants, or aneurysm clips or patients who have worked with metal
- • Patients unwilling or unable to give written informed consent
- • Pregnant women
- • Prisoners
- • Patients with an Effective Orifice Area index (EOAi) \<0.85 cm2/m2
About Cryolife, Inc.
CryoLife, Inc. is a leading medical device and tissue processing company dedicated to advancing cardiac and vascular surgery through innovative solutions. With a strong focus on improving patient outcomes, CryoLife specializes in the development and commercialization of biologic and synthetic products, including cardiac grafts and surgical adhesives. The company is committed to rigorous clinical research and trials to validate the safety and efficacy of its offerings, ensuring they meet the highest standards of quality and performance. Through its dedication to innovation and collaboration, CryoLife aims to enhance surgical practices and improve the lives of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials